Press release
Rising Chronic Kidney Disease Prevalence Drives Growth In Related Health Complications Driver: Leading Transformation in the Calciphylaxis Market in 2025
Calciphylaxis
The growing prevalence of obesity is also expected to drive the expansion of the calciphylaxis market. Obesity is characterized by excessive body fat accumulation, which increases the risk of numerous health problems, such as heart disease, diabetes, and hypertension. The rise in obesity is attributed to sedentary lifestyles, high-calorie diets, genetic factors, and limited access to healthy food. Obesity increases the risk of calciphylaxis due to metabolic dysfunction, chronic inflammation, and vascular calcification, which exacerbate calcium-phosphate imbalances and endothelial damage, particularly in individuals with CKD. In September 2023, the Centers for Disease Control and Prevention reported that in 2022, 22 states in the U.S. had an adult obesity rate of 35% or higher, up from 19 states in 2021. As such, the growing prevalence of obesity is contributing to the growth of the calciphylaxis market.
Get Your Calciphylaxis Market Report Here:
https://www.thebusinessresearchcompany.com/report/calciphylaxis-global-market-report
What is the projected compound annual growth rate (CAGR) of the calciphylaxis market from 2025 to 2034, and what factors influence it?
The calciphylaxis market has expanded rapidly, with projections to grow from $3.22 billion in 2024 to $3.55 billion in 2025, achieving a CAGR of 10.0%. Key growth factors include the increasing prevalence of chronic kidney disease, rising awareness of rare diseases, greater government support for rare disease research, a favorable regulatory landscape, and higher healthcare expenditure.
The calciphylaxis market is poised for robust growth, expanding to $5.13 billion by 2029 at a CAGR of 9.7%. Key growth drivers include an aging global population, emerging therapeutic innovations, expanded dialysis access in developing regions, increased investment in rare disease drug development, and a rising incidence of end-stage renal disease. Major trends shaping this market include improvements in dialysis and renal care, advancements in treatments for mineral and bone disorders, increased use of personalized medicine, progress in biotechnology, ongoing therapeutic advancements, and evolving healthcare policies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21124&type=smp
How are the latest trends influencing the growth of the calciphylaxis market?
Major companies in the calciphylaxis market are focusing on developing innovative therapies like enzyme replacement therapy (ERT) to improve treatment outcomes and reduce the severity of the condition. ERT replaces missing or deficient enzymes in the body and is typically used for rare genetic disorders. For example, in October 2024, Inozyme Pharma Inc., a U.S.-based biopharmaceutical company, announced positive interim results from its Phase 1 SEAPORT 1 trial of INZ-701 in end-stage kidney disease (ESKD) patients. The trial showed that INZ-701 could restore enzyme activity, helping to prevent abnormal mineralization, which is key to treating conditions like calciphylaxis caused by ENPP1 and ABCC6 deficiencies.
What are the major segments of the calciphylaxis market and their role in driving growth?
The calciphylaxis market covered in this report is segmented -
1) By Type: Non-Uremic Calciphylaxis, Ulcers And Wounds, Debridement Of Wounds
2) By Treatment: Drug Therapy, Hyperbaric Calciphylaxis Therapy
3) By Diagnosis: Deep Skin Biopsies, Blood Tests, Imaging
4) By End-Use: Hospital And Clinics, Homecare, Ambulatory Centers
Subsegments:
1) By Non-Uremic Calciphylaxis: Vascular Calcification, Soft Tissue Calcification, Cutaneous Manifestations
2) By Ulcers and Wounds: Skin Ulcers, Ischemic Wounds, Necrotic Ulcers, Pressure Ulcers
3) By Debridement Of Wounds: Surgical Debridement, Enzymatic Debridement, Autolytic Debridement, Mechanical Debridement, Biological Debridement
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21124
Which regions are key players in the growth of the calciphylaxis market?
North America was the largest region in the calciphylaxis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the calciphylaxis market?
Major companies operating in the calciphylaxis market are Baxter International Inc., Opko Health Inc., Hope Pharmaceuticals Ltd
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21124&type=smp
What Is Covered In The Calciphylaxis Global Market Report?
•Market Size Forecast: Examine the calciphylaxis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the calciphylaxis market for a structured understanding.
•Key Players Overview: Analyze major players in the calciphylaxis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the calciphylaxis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the calciphylaxis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the calciphylaxis market.
•Industry Challenges: Identify potential risks and obstacles affecting the calciphylaxis market.
•Competitive Landscape: Review strategic developments in the calciphylaxis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Chronic Kidney Disease Prevalence Drives Growth In Related Health Complications Driver: Leading Transformation in the Calciphylaxis Market in 2025 here
News-ID: 3935207 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Calciphylaxis
Global Calciphylaxis Treatment Market Outlook 2025-2034: Trends, Innovations, An …
The Calciphylaxis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Calciphylaxis Treatment Market Size and Projected Growth Rate?
The market for calciphylaxis treatment has witnessed significant expansion in the past few years. Predictions suggest that this market will witness growth from $1.86…
Calciphylaxis Market Insights 2032: Competitive Landscape, Opportunities, and Gr …
Introduction:
The calciphylaxis market is witnessing steady growth, driven by increasing awareness of this rare but severe condition, advancements in diagnostic techniques, and the development of novel therapeutic interventions. Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a debilitating disease characterized by the calcification of small blood vessels in the skin and subcutaneous tissue, leading to painful skin lesions, ulceration, and a high risk of infection. The market's expansion is…
Top Factor Driving Calciphylaxis Treatment Market Growth in 2025: Elevated Kidne …
What market dynamics are playing a key role in accelerating the growth of the calciphylaxis treatment market?
The escalating incidences of kidney diseases can potentially fuel the growth of the market for calciphylaxis treatment. Various disorders and physical conditions that impact the kidneys, crucial organs that filter waste and excess fluids from the blood to create urine, are referred to as kidney diseases. These diseases interfere with the metabolism of calcium…
Primary Catalyst Driving Calciphylaxis Treatment Market Evolution in 2025: Eleva …
What Is the Future Outlook for the Calciphylaxis Treatment Market's Size and Growth Rate?
The calciphylaxis treatment market has seen rapid expansion in recent years. It is expected to grow from $1.86 billion in 2024 to $2.05 billion in 2025 at a CAGR of 10.4%. Factors contributing to past growth include a rising incidence of calciphylaxis, greater awareness among medical professionals, improvements in healthcare infrastructure, and advancements in clinical research and…
Calciphylaxis Treatment Market Report 2024 - Calciphylaxis Treatment Market Size …
"The Business Research Company recently released a comprehensive report on the Global Calciphylaxis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the calciphylaxis treatment market…
Calciphylaxis Treatment Market Report 2024 - Calciphylaxis Treatment Market Shar …
"The Business Research Company recently released a comprehensive report on the Global Calciphylaxis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The calciphylaxis treatment market…
